Electromed, Inc. (NYSE:ELMD – Get Free Report) CFO Bradley Nagel sold 11,801 shares of Electromed stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $36.35, for a total transaction of $428,966.35. Following the completion of the transaction, the chief financial officer directly owned 19,638 shares in the company, valued at $713,841.30. This trade represents a 37.54% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Electromed Price Performance
NYSE:ELMD traded down $0.61 during mid-day trading on Monday, reaching $37.08. The stock had a trading volume of 58,565 shares, compared to its average volume of 61,376. The stock has a 50-day simple moving average of $29.79 and a two-hundred day simple moving average of $27.87. The stock has a market capitalization of $307.02 million, a PE ratio of 49.44 and a beta of 0.53. Electromed, Inc. has a 12 month low of $17.73 and a 12 month high of $40.00.
Analyst Ratings Changes
A number of research analysts recently issued reports on ELMD shares. B. Riley Financial lifted their price objective on shares of Electromed from $38.00 to $40.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. Zacks Research raised shares of Electromed from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, May 13th. Finally, Roth Mkm reissued a “buy” rating and issued a $38.00 price objective on shares of Electromed in a research note on Wednesday, February 11th. One investment analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $37.50.
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of ELMD. Kestra Advisory Services LLC acquired a new position in shares of Electromed during the fourth quarter worth $29,000. Thurston Springer Miller Herd & Titak Inc. acquired a new position in shares of Electromed during the fourth quarter worth $43,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Electromed during the second quarter worth $83,000. New York State Common Retirement Fund acquired a new position in shares of Electromed during the second quarter worth $103,000. Finally, SG Americas Securities LLC acquired a new position in shares of Electromed during the fourth quarter worth $114,000. 40.82% of the stock is currently owned by institutional investors and hedge funds.
Electromed Company Profile
Electromed Inc (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients.
The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components.
Featured Stories
- Five stocks we like better than Electromed
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.
